Biotika AS (XBRA:1BSL01AE) Operating Cash Flow per Share : €2.85 (TTM As of Jun. 2023)

View and export this data going back to 1993. Start your Free Trial

What is Biotika AS Operating Cash Flow per Share?

Biotika AS's operating cash flow per share for the six months ended in Jun. 2023 was €2.85. Biotika AS's operating cash flow per share for the trailing twelve months (TTM) ended in Jun. 2023 was €2.85.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Biotika AS was 595.80% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -56.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Biotika AS's Operating Cash Flow per Share or its related term are showing as below:

XBRA:1BSL01AE' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -56.1 Med: -4.85 Max: 20.4
Current: -56.1

During the past 13 years, Biotika AS's highest 3-Year average Operating Cash Flow per Share Growth Rate was 20.40% per year. The lowest was -56.10% per year. And the median was -4.85% per year.

XBRA:1BSL01AE's 3-Year OCF Growth Rate is ranked worse than
95.78% of 805 companies
in the Drug Manufacturers industry
Industry Median: 7.6 vs XBRA:1BSL01AE: -56.10

Biotika AS Operating Cash Flow per Share Historical Data

The historical data trend for Biotika AS's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotika AS Operating Cash Flow per Share Chart

Biotika AS Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Operating Cash Flow per Share

Get a 7-Day Free Trial

5.13

4.84

4.13

-2.39

0.41

Biotika AS Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Operating Cash Flow per Share	Get a 7-Day Free Trial															-2.39	-	0.41	-	2.85

Competitive Comparison of Biotika AS's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Biotika AS's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biotika AS's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biotika AS's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Biotika AS's Price-to-Operating-Cash-Flow falls into.

Biotika AS Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Biotika AS's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2022 is calculated as

Operating Cash Flow per Share (A: Dec. 2022 )	=	Cash Flow from Operations (A: Dec. 2022 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2022 )
	=	0.286	/	0.700
	=	0.41

Biotika AS's Operating Cash Flow per Share for the quarter that ended in Dec. 2022 is calculated as

Operating Cash Flow per Share (Q: Jun. 2023 )	=	Cash Flow from Operations (Q: Jun. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Jun. 2023 )
	=	1.992	/	0.700
	=	2.85

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €2.85

Biotika AS Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Biotika AS's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotika AS (XBRA:1BSL01AE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biotika AS (XBRA:1BSL01AE) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Slovenskc Lupca 566, Banská Bystrica, SVK, 976 13

Website

https://www.biotika.sk

Biotika AS is a manufacturer of pharmaceutical preparations for the human and veterinary application. It is engaged in the production of Active Pharmaceutical Ingredients (API), contract manufacturing of API, and contract manufacturing of final dosage formulations. It also offers research and development services. It manufacturers Polymyxine B Sulfate and other API for third parties (toll manufacturing) of pharmaceutical quality. Biotika is well known as a reliable manufacturer of high-quality pharmaceutical preparations for the human as well as veterinary application and also as a very important producer of the feed additives for breeding farm animals.

Biotika AS (XBRA:1BSL01AE) Headlines

No Headlines